LaunchWorks Manufacturing Lab is Now LaunchWorks CDMO

Pharmaceutical Technology Editors

The news comes after the company received its FDA registered ISO 13485 as a CDMO.

LaunchWorks Manufacturing Lab, a life sciences company, announced on June 8, 2020 that it is now LaunchWorks CDMO (contract development and manufacturing organization).

The news comes after the company received its FDA registered ISO 13485 as a CDMO, a press release said. Integron Global, a packaging solutions provider, acquired Launchworks in 2017 and has since added additional service offerings, including an automation program. Most recently, the company has responded to the COVID-19 pandemic.

“The enhancement of our services is an important step in showcasing our commitment to deliver a comprehensive scope of capabilities, to support our clients’ path to commercialization. Our service offerings are designed to meet each customer’s unique set of challenges,” said Jeff Kelly, general manager of LaunchWorks CDMO, in the press release. “This is a crucial step as we expand our ability to support the world’s changing needs due to the pandemic as well as incorporate automation and device manufacturing. Launchworks, with our service suite ranging from package design to fulfillment and technologies, is uniquely positioned to meet the challenge of helping companies translate their science into commercial products, thereby contributing to the improvement in world health.”

Source: LaunchWorks CDMO